Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder

D. J. Stein, C. M. Maud, C. Bouwer

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Obsessive-compulsive disorder is known to respond to several different serotonin reuptake inhibitors. However, there is limited data on the use of citalopram, a highly selective serotonin reuptake inhibitor, in this disorder. Citalopram was used on an open-label naturalistic basis in OCD patients presenting for treatment. Of 12 completers, 8 (66.7%) were responders to citalopram and the medication was well tolerated. Citalopram appears effective and safe in OCD, and deserves further study using a controlled fixed-dose design.

Original languageEnglish
Pages (from-to)29-33
Number of pages5
JournalJournal of Serotonin Research
Volume3
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder'. Together they form a unique fingerprint.

Cite this